Neuro Code Tech Holdings, LLC
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
Recorded under 2 name spellings.
3
Ending by 2030
Dec 2028
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 19, 2026The maintenance fee for Method and system for processing cancer cell electrical signals for medical therapy (US 9,032,964) comes due Nov 19, 2026. Unpaid by May 19, 2027, it lapses early.
- 1 fee due Sep 29, 2027The maintenance fee for Encoded bioelectronic method and system and calcium treatment for slaying cancer by rapid triggering of cellular apoptosis and karyorrhexis (US 9,295,835) comes due Sep 29, 2027. Unpaid by Mar 29, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 21, 2026
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Showing 1 to 7 of 7
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,707,403 | Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics In force · USPTO record | In force | USPTO record | |
| US 9,032,964 | Method and system for processing cancer cell electrical signals for medical therapy In force · USPTO record | In force | USPTO record | |
| US 8,315,712 | Hybrid scientific computer system for processing cancer cell signals as medical therapy In force · USPTO record | In force | USPTO record | |
| US 9,295,835 | Encoded bioelectronic method and system and calcium treatment for slaying cancer by rapid triggering of cellular apoptosis and karyorrhexis In force · USPTO record | In force | USPTO record | |
| US 9,492,478 | Encoded bioelectronic method and system and calcium treatment for slaying cancer by rapid triggering of cellular apoptosis and karyorrhexis In force · USPTO record | In force | USPTO record | |
| US 9,440,083 | Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics In force · USPTO record | In force | USPTO record | |
| US 9,636,507 | Rapid destruction of malignant tumors by excitotoxicity and osmotic-shock medical tactics In force · USPTO record | In force | USPTO record |
Also on record, not counted in the 7: 2 lapsed for an unpaid fee. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
2 no status recorded
Showing 1 to 2 of 2, newest filing first. An application has no patent term. A term is computed when and if it grants, and appears on that patent's own page. No title is shown: the bulk publication record carries none for these applications, and this site holds no USPTO file history for them.
| Application | Filed | Status |
|---|---|---|
| 15/464,826 | Mar 21, 2017 | No status recorded |
| 14/694,019 | Apr 23, 2015 | No status recorded |